Gynecologic Cancers Rucaparib vs Standard-of-Care Chemotherapy for BRCA1/2-Mutated, Relapsed Ovarian Cancer
Multiple Myeloma ASCO 2022: Adding ASCT to Triplet/Maintenance Therapy for Newly Diagnosed Multiple Myeloma